Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Measles
Related studies linked through entity extraction aliases.
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ProQuad™ in Healthy Children in Korea (V221-023)
- Status
- TERMINATED
- Phase
- PHASE3
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
- Status
- COMPLETED
- Phase
- PHASE3
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
- Status
- UNKNOWN
- Phase
- NA
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of ProQuad® rHA in Infants (V221-037)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Post-Training Supports for Health Workers in Benin
- Status
- COMPLETED
- Phase
- NA
Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of a Refrigerator-stable Formulation of VARIVAX®
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
ProQuad® Intramuscular vs Subcutaneous
- Status
- COMPLETED
- Phase
- PHASE3
Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
- Status
- COMPLETED
- Phase
- PHASE3